BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 24794685)

  • 1. Host natural killer immunity is a key indicator of permissiveness for donor cell engraftment in patients with severe combined immunodeficiency.
    Hassan A; Lee P; Maggina P; Xu JH; Moreira D; Slatter M; Nademi Z; Worth A; Adams S; Jones A; Cale C; Allwood Z; Rao K; Chiesa R; Amrolia P; Gaspar H; Davies EG; Veys P; Gennery A; Qasim W
    J Allergy Clin Immunol; 2014 Jun; 133(6):1660-6. PubMed ID: 24794685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between patterns of engraftment in peripheral blood and immune reconstitution after allogeneic bone marrow transplantation for (severe) combined immunodeficiency.
    van Leeuwen JE; van Tol MJ; Joosten AM; Schellekens PT; van den Bergh RL; Waaijer JL; Oudeman-Gruber NJ; van der Weijden-Ragas CP; Roos MT; Gerritsen EJ
    Blood; 1994 Dec; 84(11):3936-47. PubMed ID: 7949150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neonatal bone marrow transplantation of ADA-deficient SCID mice results in immunologic reconstitution despite low levels of engraftment and an absence of selective donor T lymphoid expansion.
    Carbonaro DA; Jin X; Cotoi D; Mi T; Yu XJ; Skelton DC; Dorey F; Kellems RE; Blackburn MR; Kohn DB
    Blood; 2008 Jun; 111(12):5745-54. PubMed ID: 18356486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current Knowledge and Priorities for Future Research in Late Effects after Hematopoietic Stem Cell Transplantation (HCT) for Severe Combined Immunodeficiency Patients: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCT.
    Heimall J; Puck J; Buckley R; Fleisher TA; Gennery AR; Neven B; Slatter M; Haddad E; Notarangelo LD; Baker KS; Dietz AC; Duncan C; Pulsipher MA; Cowan MJ
    Biol Blood Marrow Transplant; 2017 Mar; 23(3):379-387. PubMed ID: 28068510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of outcomes of hematopoietic stem cell transplantation without chemotherapy conditioning by using matched sibling and unrelated donors for treatment of severe combined immunodeficiency.
    Dvorak CC; Hassan A; Slatter MA; Hönig M; Lankester AC; Buckley RH; Pulsipher MA; Davis JH; Güngör T; Gabriel M; Bleesing JH; Bunin N; Sedlacek P; Connelly JA; Crawford DF; Notarangelo LD; Pai SY; Hassid J; Veys P; Gennery AR; Cowan MJ
    J Allergy Clin Immunol; 2014 Oct; 134(4):935-943.e15. PubMed ID: 25109802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of natural killer cell killer Ig-like receptor alloreactivity on the outcome of bone marrow stem cell transplantation for severe combined immunodeficiency (SCID).
    Keller MD; Chen DF; Condron SA; Liu N; Reinsmoen NL; Buckley RH
    J Clin Immunol; 2007 Jan; 27(1):109-16. PubMed ID: 17191149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Competition within the early B-cell compartment conditions B-cell reconstitution after hematopoietic stem cell transplantation in nonirradiated recipients.
    Liu A; Vosshenrich CA; Lagresle-Peyrou C; Malassis-Seris M; Hue C; Fischer A; Di Santo JP; Cavazzana-Calvo M
    Blood; 2006 Aug; 108(4):1123-8. PubMed ID: 16614244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minimal dose of hematopoietic stem cell transplantation without myelosuppressive conditioning for T-B+NK- severe combined immunodeficiency.
    Yi ES; Ju HY; Cho HW; Lee JW; Sung KW; Koo HH; Kang ES; Ahn KM; Kim YJ; Yoo KH
    Clin Immunol; 2023 Mar; 248():109269. PubMed ID: 36804471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Umbilical cord blood transplantation in severe T-cell immunodeficiency disorders: two-year experience.
    Knutsen AP; Wall DA
    J Clin Immunol; 2000 Nov; 20(6):466-76. PubMed ID: 11202237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of hematopoietic stem cell transplantation for adenosine deaminase-deficient severe combined immunodeficiency.
    Hassan A; Booth C; Brightwell A; Allwood Z; Veys P; Rao K; Hönig M; Friedrich W; Gennery A; Slatter M; Bredius R; Finocchi A; Cancrini C; Aiuti A; Porta F; Lanfranchi A; Ridella M; Steward C; Filipovich A; Marsh R; Bordon V; Al-Muhsen S; Al-Mousa H; Alsum Z; Al-Dhekri H; Al Ghonaium A; Speckmann C; Fischer A; Mahlaoui N; Nichols KE; Grunebaum E; Al Zahrani D; Roifman CM; Boelens J; Davies EG; Cavazzana-Calvo M; Notarangelo L; Gaspar HB;
    Blood; 2012 Oct; 120(17):3615-24; quiz 3626. PubMed ID: 22791287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infusion of Host-Derived Unlicensed NK Cells Improves Donor Engraftment in Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation.
    Alvarez M; Pierini A; Simonetta F; Baker J; Maas-Bauer K; Hirai T; Negrin RS
    Front Immunol; 2020; 11():614250. PubMed ID: 33488624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cell and B Cell immunity can be reconstituted with mismatched hematopoietic stem cell transplantation without alkylator therapy in artemis-deficient mice using anti-natural killer cell antibody and photochemically treated sensitized donor T cells.
    Xiao TZ; Singh K; Dunn E; Ramachandran R; Cowan MJ
    Biol Blood Marrow Transplant; 2012 Feb; 18(2):200-9. PubMed ID: 22015994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural killer cells weakly resist engraftment of allogeneic, long-term, multilineage-repopulating hematopoietic stem cells.
    Lee LA; Sergio JJ; Sykes M
    Transplantation; 1996 Jan; 61(1):125-32. PubMed ID: 8560550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetics of T-cell development of umbilical cord blood transplantation in severe T-cell immunodeficiency disorders.
    Knutsen AP; Wall DA
    J Allergy Clin Immunol; 1999 May; 103(5 Pt 1):823-32. PubMed ID: 10329816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematopoietic cell transplantation for treatment of primary immune deficiencies.
    Burroughs L; Woolfrey A
    Cell Ther Transplant; 2010 Aug; 2(8):. PubMed ID: 21152385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lentiviral Gene Therapy Combined with Low-Dose Busulfan in Infants with SCID-X1.
    Mamcarz E; Zhou S; Lockey T; Abdelsamed H; Cross SJ; Kang G; Ma Z; Condori J; Dowdy J; Triplett B; Li C; Maron G; Aldave Becerra JC; Church JA; Dokmeci E; Love JT; da Matta Ain AC; van der Watt H; Tang X; Janssen W; Ryu BY; De Ravin SS; Weiss MJ; Youngblood B; Long-Boyle JR; Gottschalk S; Meagher MM; Malech HL; Puck JM; Cowan MJ; Sorrentino BP
    N Engl J Med; 2019 Apr; 380(16):1525-1534. PubMed ID: 30995372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transplantation outcomes for severe combined immunodeficiency, 2000-2009.
    Pai SY; Logan BR; Griffith LM; Buckley RH; Parrott RE; Dvorak CC; Kapoor N; Hanson IC; Filipovich AH; Jyonouchi S; Sullivan KE; Small TN; Burroughs L; Skoda-Smith S; Haight AE; Grizzle A; Pulsipher MA; Chan KW; Fuleihan RL; Haddad E; Loechelt B; Aquino VM; Gillio A; Davis J; Knutsen A; Smith AR; Moore TB; Schroeder ML; Goldman FD; Connelly JA; Porteus MH; Xiang Q; Shearer WT; Fleisher TA; Kohn DB; Puck JM; Notarangelo LD; Cowan MJ; O'Reilly RJ
    N Engl J Med; 2014 Jul; 371(5):434-46. PubMed ID: 25075835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NK cell recovery, chimerism, function, and recognition in recipients of haploidentical hematopoietic cell transplantation following nonmyeloablative conditioning using a humanized anti-CD2 mAb, Medi-507.
    Koenecke C; Shaffer J; Alexander SI; Preffer F; Dombkowski D; Saidman SL; Dey B; McAfee S; Spitzer TR; Sykes M
    Exp Hematol; 2003 Oct; 31(10):911-23. PubMed ID: 14550807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multilineage hematopoietic engraftment after allogeneic peripheral blood stem cell transplantation without conditioning in SCID patients.
    Bielorai B; Trakhtenbrot L; Amariglio N; Rothman R; Tabori U; Dallal I; Golan H; Neumann Y; Reichart M; Kaplinsky C; Rechavi G; Toren A
    Bone Marrow Transplant; 2004 Aug; 34(4):317-20. PubMed ID: 15220954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term survival and late deaths after hematopoietic cell transplantation for primary immunodeficiency diseases and inborn errors of metabolism.
    Eapen M; Ahn KW; Orchard PJ; Cowan MJ; Davies SM; Fasth A; Hassebroek A; Ayas M; Bonfim C; O'Brien TA; Gross TG; Horwitz M; Horwitz E; Kapoor N; Kurtzberg J; Majhail N; Ringden O; Szabolcs P; Veys P; Baker KS
    Biol Blood Marrow Transplant; 2012 Sep; 18(9):1438-45. PubMed ID: 22430083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.